UniProt ID | MEF2D_MOUSE | |
---|---|---|
UniProt AC | Q63943 | |
Protein Name | Myocyte-specific enhancer factor 2D | |
Gene Name | Mef2d | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 514 | |
Subcellular Localization | Nucleus . Translocated by HDAC4 to nuclear dots.. | |
Protein Description | Transcriptional activator which binds specifically to the MEF2 element, 5'-YTA[AT](4)TAR-3', found in numerous muscle-specific, growth factor- and stress-induced genes. Mediates cellular functions not only in skeletal and cardiac muscle development, but also in neuronal differentiation and survival. Plays diverse roles in the control of cell growth, survival and apoptosis via p38 MAPK signaling in muscle-specific and/or growth factor-related transcription. Plays a critical role in the regulation of neuronal apoptosis.. | |
Protein Sequence | MGRKKIQIQRITDERNRQVTFTKRKFGLMKKAYELSVLCDCEIALIIFNHSNKLFQYASTDMDKVLLKYTEYNEPHESRTNADIIETLRKKGFNGCDSPEPDGEDSLEQSPLLEDKYRRASEELDGLFRRYGSSVPAPNFAMPVTVPVSNQSSMQFSNPSSSLVTPSLVTSSLTDPRLLSPQQPALQRNSVSPGLPQRPASAGAMLGGDLNSANGACPSPVGNGYVSARASPGLLPVANGNSLNKVIPAKSPPPPTHNTQLGAPSRKPDLRVITSQGGKGLMHHLTEDHLDLNNAQRLGVSQSTHSLTTPVVSVATPSLLSQGLPFSSMPTAYNTDYQLPSAELSSLPAFSSPAGLALGNVTAWQQPQPPQQPQPPQPPQSQPQPPQPQPQQPPQQQPHLVPVSLSNLIPGSPLPHVGAALTVTTHPHISIKSEPVSPSRERSPAPPPPAVFPAARPEPGEGLSSPAGGSYETGDRDDGRGDFGPTLGLLRPAPEPEAEGSAVKRMRLDTWTLK | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
20 | Phosphorylation | DERNRQVTFTKRKFG CCHHCCEEEEEHHHC | 19.76 | 15735306 | |
59 | Phosphorylation | NKLFQYASTDMDKVL CCHHHHCCCCHHHHH | 21.72 | 8663403 | |
97 (in isoform 2) | Phosphorylation | - | 69.49 | 21183079 | |
98 | Phosphorylation | KGFNGCDSPEPDGED CCCCCCCCCCCCCCC | 34.93 | 25521595 | |
106 | Phosphorylation | PEPDGEDSLEQSPLL CCCCCCCCCCCCHHH | 29.51 | 24925903 | |
107 (in isoform 2) | Phosphorylation | - | 12.27 | 21183079 | |
110 | Phosphorylation | GEDSLEQSPLLEDKY CCCCCCCCHHHHHHH | 14.24 | 24925903 | |
121 | Phosphorylation | EDKYRRASEELDGLF HHHHHHHHHHHHHHH | 29.77 | 22942356 | |
180 | Phosphorylation | LTDPRLLSPQQPALQ CCCHHHCCCCCCHHH | 25.84 | 27087446 | |
190 | Phosphorylation | QPALQRNSVSPGLPQ CCHHHCCCCCCCCCC | 26.59 | 22817900 | |
192 | Phosphorylation | ALQRNSVSPGLPQRP HHHCCCCCCCCCCCC | 17.05 | 29472430 | |
201 | Phosphorylation | GLPQRPASAGAMLGG CCCCCCCCCCCCCCC | 29.89 | 24759943 | |
212 | Phosphorylation | MLGGDLNSANGACPS CCCCCCCCCCCCCCC | 30.34 | 24759943 | |
219 | Phosphorylation | SANGACPSPVGNGYV CCCCCCCCCCCCCCE | 31.91 | 24759943 | |
225 | Phosphorylation | PSPVGNGYVSARASP CCCCCCCCEECCCCC | 8.67 | 24759943 | |
231 | Phosphorylation | GYVSARASPGLLPVA CCEECCCCCCCCCCC | 17.59 | 25521595 | |
242 | Phosphorylation | LPVANGNSLNKVIPA CCCCCCCCCCCCCCC | 34.42 | 25619855 | |
245 | Acetylation | ANGNSLNKVIPAKSP CCCCCCCCCCCCCCC | 47.00 | - | |
251 | Phosphorylation | NKVIPAKSPPPPTHN CCCCCCCCCCCCCCC | 44.75 | 26824392 | |
256 | Phosphorylation | AKSPPPPTHNTQLGA CCCCCCCCCCCCCCC | 33.27 | 28833060 | |
259 | Phosphorylation | PPPPTHNTQLGAPSR CCCCCCCCCCCCCCC | 19.98 | 28833060 | |
286 | Phosphorylation | KGLMHHLTEDHLDLN CHHHHHHCHHCCCCC | 34.70 | 29899451 | |
432 | Acetylation | THPHISIKSEPVSPS CCCCCEECCCCCCCC | 41.81 | 59823 | |
433 | Phosphorylation | HPHISIKSEPVSPSR CCCCEECCCCCCCCC | 45.52 | 21743459 | |
437 | Phosphorylation | SIKSEPVSPSRERSP EECCCCCCCCCCCCC | 28.07 | 25521595 | |
439 | Phosphorylation | KSEPVSPSRERSPAP CCCCCCCCCCCCCCC | 38.99 | 25521595 | |
443 | Phosphorylation | VSPSRERSPAPPPPA CCCCCCCCCCCCCCC | 22.21 | 28066266 | |
464 | Phosphorylation | PEPGEGLSSPAGGSY CCCCCCCCCCCCCCC | 45.17 | 25338131 | |
465 | Phosphorylation | EPGEGLSSPAGGSYE CCCCCCCCCCCCCCC | 24.66 | 29514104 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
121 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
121 | S | Phosphorylation | Kinase | PKACA | P05132 | PSP |
121 | S | Phosphorylation | Kinase | P38A | Q16539 | PSP |
121 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
121 | S | Phosphorylation | Kinase | PKA | - | Uniprot |
180 | S | Phosphorylation | Kinase | MAPK7 | Q13164 | GPS |
180 | S | Phosphorylation | Kinase | MK07 | Q9WVS8 | PhosphoELM |
190 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
190 | S | Phosphorylation | Kinase | PKACA | P05132 | PSP |
190 | S | Phosphorylation | Kinase | P38A | Q16539 | PSP |
190 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
190 | S | Phosphorylation | Kinase | PKA | - | Uniprot |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MEF2D_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
KDM1A_HUMAN | KDM1A | physical | 20833138 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large scale localization of protein phosphorylation by use ofelectron capture dissociation mass spectrometry."; Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.; Mol. Cell. Proteomics 8:904-912(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-251, AND MASSSPECTROMETRY. | |
"Protein kinase A represses skeletal myogenesis by targeting myocyteenhancer factor 2D."; Du M., Perry R.L.S., Nowacki N.B., Gordon J.W., Salma J., Zhao J.,Aziz A., Chan J., Siu K.W.M., McDermott J.C.; Mol. Cell. Biol. 28:2952-2970(2008). Cited for: PHOSPHORYLATION AT SER-121 AND SER-190, INTERACTION WITH HDAC4,FUNCTION, SUBCELLULAR LOCATION, MASS SPECTROMETRY, AND MUTAGENESIS OFTHR-20; SER-121 AND SER-190. | |
"Calpain-regulated p35/cdk5 plays a central role in dopaminergicneuron death through modulation of the transcription factor myocyteenhancer factor 2."; Smith P.D., Mount M.P., Shree R., Callaghan S., Slack R.S.,Anisman H., Vincent I., Wang X., Mao Z., Park D.S.; J. Neurosci. 26:440-447(2006). Cited for: PHOSPHORYLATION AT SER-437, FUNCTION, TISSUE SPECIFICITY, ANDMUTAGENESIS OF SER-437. |